Filing Flows › Axogen (AXGN) › Q2 2026 › vs Q1 2026
Axogen (AXGN) Q2 2026 vs Q1 2026 (quarter over quarter)
Axogen's revenue rose $8.3M (+13%) from $61.5M in Q1 2026 to $69.7M in Q2 2026.
Axogen, Q2 2026: revenue $69.7M (+23% year over year), operating margin -3.1%, net loss $1.5M, operating cash flow $7.2M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Free cash flow margin | 9.1% | -2.0% | +11.1 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $69.7M | $61.5M | $8.3M | +13% |
| Other income, net | $640K | −$16.8M | $17.4M | — |
| Net loss | $1.5M | $19.6M | −$18.1M | -92% |
| Costs & expenses | $71.9M | $81.0M | −$9.2M | -11% |
| Operating costs | $71.9M | $64.3M | $7.6M | +12% |
| Cost of revenue | $19.1M | $15.3M | $3.8M | +25% |
| Research & development | $8.6M | $7.5M | $1.1M | +14% |
| Sales & marketing | $30.8M | $28.6M | $2.2M | +8% |
| General & admin | $13.4M | $12.9M | $543K | +4% |
| Operating cash sources | $10.5M | $8.5M | $1.9M | +23% |
| Depreciation & amortization | $1.7M | $1.7M | $13K | +0.8% |
| Share-based compensation | $8.8M | $6.8M | $1.9M | +28% |
| Net loss absorbed | $1.5M | $19.6M | −$18.1M | -92% |
| Working capital & other | $1.7M | −$12.6M | $14.3M | — |
| Operating cash flow | $7.2M | $1.6M | $5.7M | +361% |
| Free cash flow (OCF − capex) | $6.3M | −$1.2M | $7.6M | — |
| Capital expenditures | $893K | $2.8M | −$1.9M | -68% |
Questions
How much did Axogen's revenue grow quarter over quarter in Q2 2026?
Axogen's revenue rose $8.3M (+13%) from $61.5M in Q1 2026 to $69.7M in Q2 2026.